These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15894085)

  • 21. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
    Gassen DT; Herter LD; Chagas JK; Schmid H
    Arch Gynecol Obstet; 2013 Feb; 287(2):289-94. PubMed ID: 22976131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missed contraceptive pill recommendations.
    Penney G; Brechin S; Glasier A; Bigrigg A
    Lancet; 2005 Oct; 366(9493):1264. PubMed ID: 16214594
    [No Abstract]   [Full Text] [Related]  

  • 25. [Stediril].
    Csech J; Gervais C
    Soins Gynecol Obstet Pueric Pediatr; 1984 Feb; (33):I-II. PubMed ID: 6562744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined hormonal contraception.
    Calderoni ME; Coupey SM
    Adolesc Med Clin; 2005 Oct; 16(3):517-37. PubMed ID: 16183537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users.
    Bodner K; Bodner-Adler B; Grünberger W
    Arch Gynecol Obstet; 2011 Mar; 283(3):525-30. PubMed ID: 20111970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
    Cremer P; Vekemans M
    Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
    [No Abstract]   [Full Text] [Related]  

  • 31. User characteristics and oral contraceptive compliance in Egypt.
    Trottier DA; Potter LS; Taylor BA; Glover LH
    Stud Fam Plann; 1994; 25(5):284-92. PubMed ID: 7871553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormonal contraception and focal nodular hyperplasia].
    Wedig MP; Altmann C
    Zentralbl Gynakol; 1991; 113(24):1399-402. PubMed ID: 1667053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral contraceptive use and protective behavior after missed pills.
    Oakley D; Potter L; de Leon-Wong E; Visness C
    Fam Plann Perspect; 1997; 29(6):277-9, 287. PubMed ID: 9429874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [General practitioners' (GPs) practice regarding the line to take in case of missed pill].
    Bertin-Steunou V; Bouquet E; Cailliez E; Tanguy M; Fanello S
    J Gynecol Obstet Biol Reprod (Paris); 2010 May; 39(3):208-17. PubMed ID: 20334984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
    Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
    Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
    Yonkers KA; Brown C; Pearlstein TB; Foegh M; Sampson-Landers C; Rapkin A
    Obstet Gynecol; 2005 Sep; 106(3):492-501. PubMed ID: 16135578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating information on oral contraceptive use: a randomized controlled trial to assess missed pill instructions.
    Chin-Quee D; Wong E; Cuthbertson C
    Hum Reprod; 2006 Dec; 21(12):3137-45. PubMed ID: 16931805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ
    Fortschr Med; 1982 Apr; 100(16):764-7. PubMed ID: 6211403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of triphasic Tri-Regol tablet in women of borderline age.
    Takács G
    Ther Hung; 1991; 39(4):188-91. PubMed ID: 1811332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.